

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sodium ion export (GO:0071436) | 6.21038647 |
| 2 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.78827881 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.78447648 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.75887077 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68568444 |
| 6 | vocalization behavior (GO:0071625) | 5.63724486 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.55677061 |
| 8 | glutamate secretion (GO:0014047) | 5.36360552 |
| 9 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.27588941 |
| 10 | protein localization to synapse (GO:0035418) | 5.21807421 |
| 11 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.17856982 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.12084743 |
| 13 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.02855726 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.95703536 |
| 15 | locomotory exploration behavior (GO:0035641) | 4.86931337 |
| 16 | L-amino acid import (GO:0043092) | 4.86077272 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.86023195 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.76492304 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.73838511 |
| 20 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.69612716 |
| 21 | synaptic vesicle maturation (GO:0016188) | 4.65943218 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.60919643 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 4.60022634 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.59429279 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.48590940 |
| 26 | presynaptic membrane assembly (GO:0097105) | 4.45095915 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.44985823 |
| 28 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.36565435 |
| 29 | amino acid import (GO:0043090) | 4.33132006 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.31789036 |
| 31 | long-term synaptic potentiation (GO:0060291) | 4.31082531 |
| 32 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.27676820 |
| 33 | potassium ion homeostasis (GO:0055075) | 4.26861592 |
| 34 | presynaptic membrane organization (GO:0097090) | 4.15812811 |
| 35 | regulation of postsynaptic membrane potential (GO:0060078) | 4.12849942 |
| 36 | exploration behavior (GO:0035640) | 4.12361384 |
| 37 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.12100939 |
| 38 | positive regulation of synapse maturation (GO:0090129) | 4.11917237 |
| 39 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.11838519 |
| 40 | cellular sodium ion homeostasis (GO:0006883) | 4.09527052 |
| 41 | cell communication by electrical coupling (GO:0010644) | 4.08851193 |
| 42 | neurotransmitter secretion (GO:0007269) | 4.07347631 |
| 43 | response to histamine (GO:0034776) | 4.06580984 |
| 44 | potassium ion import (GO:0010107) | 4.05630319 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 4.03782588 |
| 46 | axon ensheathment in central nervous system (GO:0032291) | 3.98773423 |
| 47 | central nervous system myelination (GO:0022010) | 3.98773423 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.95505992 |
| 49 | layer formation in cerebral cortex (GO:0021819) | 3.94813949 |
| 50 | neuronal ion channel clustering (GO:0045161) | 3.94073148 |
| 51 | postsynaptic membrane organization (GO:0001941) | 3.94006713 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.92465232 |
| 53 | positive regulation of dendritic spine development (GO:0060999) | 3.90869101 |
| 54 | long-term memory (GO:0007616) | 3.82959769 |
| 55 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.77907374 |
| 56 | behavioral defense response (GO:0002209) | 3.74307480 |
| 57 | behavioral fear response (GO:0001662) | 3.74307480 |
| 58 | neuromuscular process controlling balance (GO:0050885) | 3.72429808 |
| 59 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.70947857 |
| 60 | positive regulation of neurotransmitter transport (GO:0051590) | 3.69355994 |
| 61 | regulation of glutamate secretion (GO:0014048) | 3.67868296 |
| 62 | behavioral response to cocaine (GO:0048148) | 3.66388421 |
| 63 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.66123110 |
| 64 | regulation of synapse structural plasticity (GO:0051823) | 3.65906721 |
| 65 | synaptic vesicle endocytosis (GO:0048488) | 3.65474447 |
| 66 | neuron recognition (GO:0008038) | 3.61837377 |
| 67 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.56407759 |
| 68 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.55445791 |
| 69 | fear response (GO:0042596) | 3.55150578 |
| 70 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.54158399 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.52367520 |
| 72 | acidic amino acid transport (GO:0015800) | 3.49742691 |
| 73 | regulation of ARF protein signal transduction (GO:0032012) | 3.48320250 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.48247467 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.47400898 |
| 76 | long term synaptic depression (GO:0060292) | 3.43616140 |
| 77 | neurotransmitter uptake (GO:0001504) | 3.38655066 |
| 78 | membrane depolarization (GO:0051899) | 3.35516631 |
| 79 | neuromuscular process controlling posture (GO:0050884) | 3.35339799 |
| 80 | regulation of dendritic spine development (GO:0060998) | 3.32497693 |
| 81 | neurotransmitter transport (GO:0006836) | 3.31147117 |
| 82 | cerebellar granule cell differentiation (GO:0021707) | 3.30865973 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.30516189 |
| 84 | dendritic spine morphogenesis (GO:0060997) | 3.29320788 |
| 85 | serotonin metabolic process (GO:0042428) | 3.28987590 |
| 86 | regulation of female receptivity (GO:0045924) | 3.28910318 |
| 87 | regulation of synapse maturation (GO:0090128) | 3.27777181 |
| 88 | positive regulation of synaptic transmission (GO:0050806) | 3.27376029 |
| 89 | neuromuscular synaptic transmission (GO:0007274) | 3.27189514 |
| 90 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.25847628 |
| 91 | learning (GO:0007612) | 3.25333487 |
| 92 | axonal fasciculation (GO:0007413) | 3.23965953 |
| 93 | startle response (GO:0001964) | 3.23145976 |
| 94 | transmission of nerve impulse (GO:0019226) | 3.22756246 |
| 95 | female mating behavior (GO:0060180) | 3.19595875 |
| 96 | negative regulation of amino acid transport (GO:0051956) | 3.19586327 |
| 97 | cell communication involved in cardiac conduction (GO:0086065) | 3.18693523 |
| 98 | regulation of neurotransmitter transport (GO:0051588) | 3.18613598 |
| 99 | synaptic vesicle transport (GO:0048489) | 3.18232988 |
| 100 | establishment of synaptic vesicle localization (GO:0097480) | 3.18232988 |
| 101 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.18082838 |
| 102 | regulation of synaptic transmission (GO:0050804) | 3.17740961 |
| 103 | cellular potassium ion homeostasis (GO:0030007) | 3.17478549 |
| 104 | vesicle docking involved in exocytosis (GO:0006904) | 3.15023933 |
| 105 | cerebellar Purkinje cell layer development (GO:0021680) | 3.13992036 |
| 106 | cell differentiation in hindbrain (GO:0021533) | 3.13879893 |
| 107 | L-glutamate transport (GO:0015813) | 3.13551969 |
| 108 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.11222036 |
| 109 | innervation (GO:0060384) | 3.11167234 |
| 110 | synaptic transmission (GO:0007268) | 3.10136611 |
| 111 | gamma-aminobutyric acid transport (GO:0015812) | 3.08741482 |
| 112 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.08671611 |
| 113 | activation of protein kinase A activity (GO:0034199) | 3.08535251 |
| 114 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08329334 |
| 115 | regulation of neurotransmitter levels (GO:0001505) | 3.07655877 |
| 116 | auditory behavior (GO:0031223) | 3.05115940 |
| 117 | proline transport (GO:0015824) | 3.05064926 |
| 118 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.04864170 |
| 119 | neuromuscular process (GO:0050905) | 3.04801874 |
| 120 | synaptic transmission, dopaminergic (GO:0001963) | 3.04636393 |
| 121 | mechanosensory behavior (GO:0007638) | 3.04360422 |
| 122 | cochlea development (GO:0090102) | 3.03625087 |
| 123 | detection of calcium ion (GO:0005513) | 3.03179152 |
| 124 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.02993945 |
| 125 | dendritic spine organization (GO:0097061) | 3.00485318 |
| 126 | negative regulation of dendrite development (GO:2000171) | 2.99201207 |
| 127 | membrane depolarization during action potential (GO:0086010) | 2.98791827 |
| 128 | striatum development (GO:0021756) | 2.96440570 |
| 129 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.95504027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.13317220 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.50814028 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.24865453 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12579487 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09085706 |
| 6 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.77808399 |
| 7 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74292937 |
| 8 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.73688096 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65202994 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65202994 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59868215 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.55539086 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.49710191 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45768761 |
| 15 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43737952 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42460027 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.35615229 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.34847155 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.23433224 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19492584 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.15227080 |
| 22 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11145862 |
| 23 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10871580 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.10327732 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.10260034 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.05108665 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04552494 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95779513 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.90702960 |
| 30 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.88869760 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86460480 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83099020 |
| 33 | P300_19829295_ChIP-Seq_ESCs_Human | 1.79368457 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.78223425 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77951869 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73949987 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.73807988 |
| 38 | * NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.72929849 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67475422 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54682622 |
| 41 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54339344 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.52737064 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51316539 |
| 44 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50305540 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.49789933 |
| 46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48582942 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43336742 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41857618 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39456051 |
| 50 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38410953 |
| 51 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37465389 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36291940 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.35781988 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35474679 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.35281984 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.35133067 |
| 57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33957601 |
| 58 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32887809 |
| 59 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30315557 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30282487 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29158343 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28444272 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26922264 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25472435 |
| 65 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.21477660 |
| 66 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21092996 |
| 67 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20483045 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19922380 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19887214 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.18780875 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.16915480 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16108598 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14258734 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14221117 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.13866636 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13566203 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12183365 |
| 78 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11655641 |
| 79 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11271550 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09394958 |
| 81 | JUN_21703547_ChIP-Seq_K562_Human | 1.09363965 |
| 82 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.09141016 |
| 83 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08363143 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05549084 |
| 85 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03354539 |
| 86 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02948096 |
| 87 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02472048 |
| 88 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.02147135 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01846061 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01746632 |
| 91 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01692677 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01338905 |
| 93 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01279467 |
| 94 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99650472 |
| 95 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99644448 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.99394492 |
| 97 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99147475 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97439137 |
| 99 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97330766 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96744075 |
| 101 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.95905472 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95374955 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94991631 |
| 104 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94710342 |
| 105 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93989467 |
| 106 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93918151 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93851617 |
| 108 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93488962 |
| 109 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93477867 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92454207 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92340010 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92340010 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91818986 |
| 114 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91392823 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.90488119 |
| 116 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88247709 |
| 117 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87858455 |
| 118 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86747319 |
| 119 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.85901797 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85279617 |
| 121 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85246250 |
| 122 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.82709080 |
| 123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.82284505 |
| 124 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.82067413 |
| 125 | * PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81055508 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79280149 |
| 127 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78434815 |
| 128 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.77487179 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75165482 |
| 130 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75093901 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.80853733 |
| 2 | * MP0003880_abnormal_central_pattern | 4.83391578 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.35967296 |
| 4 | MP0009745_abnormal_behavioral_response | 3.77303343 |
| 5 | MP0004270_analgesia | 3.69505366 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.64403562 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.43830770 |
| 8 | * MP0002064_seizures | 3.30457319 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 3.09732888 |
| 10 | MP0002736_abnormal_nociception_after | 3.02493491 |
| 11 | MP0009046_muscle_twitch | 3.02297877 |
| 12 | MP0002822_catalepsy | 3.01500341 |
| 13 | * MP0002272_abnormal_nervous_system | 2.62852976 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.59859129 |
| 15 | MP0001486_abnormal_startle_reflex | 2.57167393 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.41665795 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.41550634 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.33525930 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.08694502 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.08367057 |
| 21 | MP0005423_abnormal_somatic_nervous | 1.97295116 |
| 22 | MP0003787_abnormal_imprinting | 1.91002733 |
| 23 | MP0003879_abnormal_hair_cell | 1.90705869 |
| 24 | MP0001970_abnormal_pain_threshold | 1.84890427 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.82884776 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.82400358 |
| 27 | MP0001529_abnormal_vocalization | 1.77506505 |
| 28 | MP0004924_abnormal_behavior | 1.74771713 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.74771713 |
| 30 | MP0003329_amyloid_beta_deposits | 1.69991552 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.67644084 |
| 32 | MP0001984_abnormal_olfaction | 1.65492084 |
| 33 | MP0008569_lethality_at_weaning | 1.64299554 |
| 34 | MP0000920_abnormal_myelination | 1.61295974 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.60134966 |
| 36 | MP0004811_abnormal_neuron_physiology | 1.60041697 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.57509873 |
| 38 | MP0003690_abnormal_glial_cell | 1.57062213 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.52474470 |
| 40 | * MP0002184_abnormal_innervation | 1.51767273 |
| 41 | * MP0000778_abnormal_nervous_system | 1.50668348 |
| 42 | MP0001188_hyperpigmentation | 1.49733387 |
| 43 | MP0001905_abnormal_dopamine_level | 1.48173139 |
| 44 | * MP0002066_abnormal_motor_capabilities/c | 1.36300274 |
| 45 | MP0003633_abnormal_nervous_system | 1.28928080 |
| 46 | MP0004858_abnormal_nervous_system | 1.28584895 |
| 47 | * MP0002882_abnormal_neuron_morphology | 1.28003063 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.26439992 |
| 49 | * MP0000955_abnormal_spinal_cord | 1.24514608 |
| 50 | MP0003122_maternal_imprinting | 1.18761306 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.17213606 |
| 52 | MP0004147_increased_porphyrin_level | 1.12780453 |
| 53 | MP0004142_abnormal_muscle_tone | 1.12474725 |
| 54 | MP0003631_nervous_system_phenotype | 1.08626273 |
| 55 | MP0000751_myopathy | 1.07615211 |
| 56 | MP0008872_abnormal_physiological_respon | 1.05750274 |
| 57 | MP0004885_abnormal_endolymph | 1.04669393 |
| 58 | MP0008874_decreased_physiological_sensi | 1.01607965 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.00460949 |
| 60 | * MP0002152_abnormal_brain_morphology | 0.98704595 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 0.95001751 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.94809888 |
| 63 | MP0004484_altered_response_of | 0.94712606 |
| 64 | MP0002638_abnormal_pupillary_reflex | 0.93994250 |
| 65 | MP0002069_abnormal_eating/drinking_beha | 0.93977193 |
| 66 | MP0010386_abnormal_urinary_bladder | 0.92978526 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.91221667 |
| 68 | MP0001963_abnormal_hearing_physiology | 0.90427240 |
| 69 | MP0004085_abnormal_heartbeat | 0.90030317 |
| 70 | MP0005535_abnormal_body_temperature | 0.88814152 |
| 71 | MP0001346_abnormal_lacrimal_gland | 0.88021054 |
| 72 | MP0004215_abnormal_myocardial_fiber | 0.87622563 |
| 73 | MP0005171_absent_coat_pigmentation | 0.86655061 |
| 74 | MP0002229_neurodegeneration | 0.86043084 |
| 75 | MP0004742_abnormal_vestibular_system | 0.84575136 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.81755570 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.81494976 |
| 78 | MP0001664_abnormal_digestion | 0.79497031 |
| 79 | MP0003075_altered_response_to | 0.77314318 |
| 80 | MP0001485_abnormal_pinna_reflex | 0.76593534 |
| 81 | MP0005409_darkened_coat_color | 0.72739147 |
| 82 | MP0000604_amyloidosis | 0.72404161 |
| 83 | MP0005499_abnormal_olfactory_system | 0.71442588 |
| 84 | MP0005394_taste/olfaction_phenotype | 0.71442588 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.69308935 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 0.69256030 |
| 87 | MP0001177_atelectasis | 0.68855131 |
| 88 | MP0004510_myositis | 0.67571976 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.65682245 |
| 90 | MP0003632_abnormal_nervous_system | 0.63515557 |
| 91 | MP0001299_abnormal_eye_distance/ | 0.63159432 |
| 92 | MP0006292_abnormal_olfactory_placode | 0.62312288 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.61862637 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.60329729 |
| 95 | MP0003121_genomic_imprinting | 0.57063326 |
| 96 | MP0004043_abnormal_pH_regulation | 0.54058002 |
| 97 | MP0003634_abnormal_glial_cell | 0.54003678 |
| 98 | MP0000026_abnormal_inner_ear | 0.53887458 |
| 99 | MP0010768_mortality/aging | 0.53711601 |
| 100 | MP0004233_abnormal_muscle_weight | 0.53651509 |
| 101 | MP0003283_abnormal_digestive_organ | 0.53592210 |
| 102 | MP0001943_abnormal_respiration | 0.53390397 |
| 103 | MP0002090_abnormal_vision | 0.50955333 |
| 104 | * MP0003861_abnormal_nervous_system | 0.49916564 |
| 105 | MP0000579_abnormal_nail_morphology | 0.49840717 |
| 106 | MP0010769_abnormal_survival | 0.46698975 |
| 107 | * MP0003956_abnormal_body_size | 0.46555623 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.46536876 |
| 109 | MP0003123_paternal_imprinting | 0.46534850 |
| 110 | MP0002082_postnatal_lethality | 0.46509257 |
| 111 | MP0010770_preweaning_lethality | 0.46509257 |
| 112 | MP0003137_abnormal_impulse_conducting | 0.46286644 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.46240343 |
| 114 | MP0004130_abnormal_muscle_cell | 0.45915018 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.45747107 |
| 116 | MP0005620_abnormal_muscle_contractility | 0.45673224 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.42652705 |
| 118 | MP0002873_normal_phenotype | 0.42501578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.65621819 |
| 2 | Myokymia (HP:0002411) | 6.34779285 |
| 3 | Focal seizures (HP:0007359) | 6.24552010 |
| 4 | Epileptic encephalopathy (HP:0200134) | 6.16903910 |
| 5 | Atonic seizures (HP:0010819) | 5.73556943 |
| 6 | Hyperventilation (HP:0002883) | 5.32096958 |
| 7 | Febrile seizures (HP:0002373) | 5.16861089 |
| 8 | Visual hallucinations (HP:0002367) | 5.09923852 |
| 9 | Absence seizures (HP:0002121) | 4.82418301 |
| 10 | Dialeptic seizures (HP:0011146) | 4.60121799 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 4.08774196 |
| 12 | Broad-based gait (HP:0002136) | 4.08357090 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.88943409 |
| 14 | Papilledema (HP:0001085) | 3.76960754 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.62271295 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.46897636 |
| 17 | Poor eye contact (HP:0000817) | 3.44513560 |
| 18 | Tetraplegia (HP:0002445) | 3.28514943 |
| 19 | Cerebral hypomyelination (HP:0006808) | 3.19396486 |
| 20 | Limb dystonia (HP:0002451) | 3.16335978 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.12789897 |
| 22 | Truncal ataxia (HP:0002078) | 3.07235070 |
| 23 | Obstructive sleep apnea (HP:0002870) | 3.01687710 |
| 24 | Dysmetria (HP:0001310) | 2.99206573 |
| 25 | Impaired social interactions (HP:0000735) | 2.97991045 |
| 26 | Abnormal social behavior (HP:0012433) | 2.97991045 |
| 27 | Action tremor (HP:0002345) | 2.97254435 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 2.96758374 |
| 29 | Anxiety (HP:0000739) | 2.96627227 |
| 30 | Depression (HP:0000716) | 2.93700189 |
| 31 | Excessive salivation (HP:0003781) | 2.91528766 |
| 32 | Drooling (HP:0002307) | 2.91528766 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.86402134 |
| 34 | Abnormality of the lower motor neuron (HP:0002366) | 2.83282110 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.81132890 |
| 36 | Dysmetric saccades (HP:0000641) | 2.80193291 |
| 37 | Neuronal loss in central nervous system (HP:0002529) | 2.75580237 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69676430 |
| 39 | Supranuclear gaze palsy (HP:0000605) | 2.62156219 |
| 40 | Akinesia (HP:0002304) | 2.60190742 |
| 41 | Cerebral inclusion bodies (HP:0100314) | 2.59167854 |
| 42 | Protruding tongue (HP:0010808) | 2.55936249 |
| 43 | Absent speech (HP:0001344) | 2.55377759 |
| 44 | EEG with generalized epileptiform discharges (HP:0011198) | 2.54392077 |
| 45 | Inability to walk (HP:0002540) | 2.52335548 |
| 46 | Clonus (HP:0002169) | 2.52320391 |
| 47 | Impaired vibratory sensation (HP:0002495) | 2.50188657 |
| 48 | Scanning speech (HP:0002168) | 2.49226934 |
| 49 | Sleep apnea (HP:0010535) | 2.47335245 |
| 50 | Stereotypic behavior (HP:0000733) | 2.46628682 |
| 51 | * Amblyopia (HP:0000646) | 2.45055914 |
| 52 | Delusions (HP:0000746) | 2.44407057 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.43057361 |
| 54 | Diplopia (HP:0000651) | 2.43057361 |
| 55 | Hemiparesis (HP:0001269) | 2.41815531 |
| 56 | Postural instability (HP:0002172) | 2.41607364 |
| 57 | Bradykinesia (HP:0002067) | 2.41521071 |
| 58 | Insidious onset (HP:0003587) | 2.37660795 |
| 59 | Termporal pattern (HP:0011008) | 2.37660795 |
| 60 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.32265609 |
| 61 | Apathy (HP:0000741) | 2.32250147 |
| 62 | Status epilepticus (HP:0002133) | 2.32165802 |
| 63 | Hypsarrhythmia (HP:0002521) | 2.31210462 |
| 64 | Peripheral hypomyelination (HP:0007182) | 2.29002518 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.28661981 |
| 66 | Urinary urgency (HP:0000012) | 2.28478615 |
| 67 | Progressive inability to walk (HP:0002505) | 2.24016596 |
| 68 | Ankle clonus (HP:0011448) | 2.22423194 |
| 69 | Insomnia (HP:0100785) | 2.22278275 |
| 70 | Gait imbalance (HP:0002141) | 2.21661074 |
| 71 | Incomplete penetrance (HP:0003829) | 2.19125901 |
| 72 | Rigidity (HP:0002063) | 2.18250691 |
| 73 | Thickened helices (HP:0000391) | 2.17409810 |
| 74 | Focal dystonia (HP:0004373) | 2.16863942 |
| 75 | Resting tremor (HP:0002322) | 2.16553692 |
| 76 | Blue irides (HP:0000635) | 2.14146392 |
| 77 | Spastic tetraparesis (HP:0001285) | 2.13944906 |
| 78 | Genetic anticipation (HP:0003743) | 2.13361458 |
| 79 | Torticollis (HP:0000473) | 2.12870449 |
| 80 | Generalized myoclonic seizures (HP:0002123) | 2.12854978 |
| 81 | Diminished motivation (HP:0000745) | 2.08329485 |
| 82 | Abnormality of saccadic eye movements (HP:0000570) | 2.07581716 |
| 83 | Annular pancreas (HP:0001734) | 2.07343377 |
| 84 | CNS hypomyelination (HP:0003429) | 2.06226645 |
| 85 | Choreoathetosis (HP:0001266) | 2.05430539 |
| 86 | Pheochromocytoma (HP:0002666) | 2.05366636 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.05180044 |
| 88 | Spastic gait (HP:0002064) | 2.03764693 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01683798 |
| 90 | Polyphagia (HP:0002591) | 2.01537639 |
| 91 | Medial flaring of the eyebrow (HP:0010747) | 2.00402877 |
| 92 | Gait ataxia (HP:0002066) | 2.00263673 |
| 93 | Abnormality of salivation (HP:0100755) | 1.99056715 |
| 94 | Neurofibrillary tangles (HP:0002185) | 1.98785946 |
| 95 | Bundle branch block (HP:0011710) | 1.97526044 |
| 96 | Rapidly progressive (HP:0003678) | 1.96935123 |
| 97 | Nephrogenic diabetes insipidus (HP:0009806) | 1.90250591 |
| 98 | Acute necrotizing encephalopathy (HP:0006965) | 1.88385355 |
| 99 | Hydroureter (HP:0000072) | 1.87968262 |
| 100 | Split foot (HP:0001839) | 1.86674307 |
| 101 | Ventricular fibrillation (HP:0001663) | 1.86616355 |
| 102 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.86592568 |
| 103 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.86461929 |
| 104 | Absent/shortened dynein arms (HP:0200106) | 1.86461929 |
| 105 | Abnormal hair whorl (HP:0010721) | 1.86120317 |
| 106 | Craniofacial dystonia (HP:0012179) | 1.85945811 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 1.85913403 |
| 108 | Lower limb muscle weakness (HP:0007340) | 1.84712399 |
| 109 | Aplasia involving bones of the extremities (HP:0009825) | 1.82838464 |
| 110 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.82838464 |
| 111 | Aplasia of the phalanges of the hand (HP:0009802) | 1.82838464 |
| 112 | Increased circulating renin level (HP:0000848) | 1.82104954 |
| 113 | Postural tremor (HP:0002174) | 1.81757906 |
| 114 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80337536 |
| 115 | Psychosis (HP:0000709) | 1.80309594 |
| 116 | Megalencephaly (HP:0001355) | 1.80281895 |
| 117 | Abnormality of the corticospinal tract (HP:0002492) | 1.77807070 |
| 118 | Progressive macrocephaly (HP:0004481) | 1.77604256 |
| 119 | Specific learning disability (HP:0001328) | 1.77551818 |
| 120 | Memory impairment (HP:0002354) | 1.77507193 |
| 121 | Spinal canal stenosis (HP:0003416) | 1.75858788 |
| 122 | Fair hair (HP:0002286) | 1.75756461 |
| 123 | Hypoventilation (HP:0002791) | 1.72783058 |
| 124 | Hyperthyroidism (HP:0000836) | 1.72369346 |
| 125 | Generalized hypopigmentation of hair (HP:0011358) | 1.71095764 |
| 126 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.70492458 |
| 127 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.70492458 |
| 128 | Hemiplegia (HP:0002301) | 1.68816041 |
| 129 | Lower limb asymmetry (HP:0100559) | 1.67796251 |
| 130 | Mutism (HP:0002300) | 1.67281203 |
| 131 | Intention tremor (HP:0002080) | 1.67223011 |
| 132 | Lower limb amyotrophy (HP:0007210) | 1.65601778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.65979082 |
| 2 | NTRK3 | 4.50390442 |
| 3 | CASK | 3.90877281 |
| 4 | RIPK4 | 3.08923518 |
| 5 | MAP3K4 | 3.02902382 |
| 6 | MAP3K9 | 2.98213497 |
| 7 | DAPK2 | 2.92066864 |
| 8 | MAP3K12 | 2.89146094 |
| 9 | MAP2K7 | 2.82955669 |
| 10 | DAPK1 | 2.39637917 |
| 11 | CDK19 | 2.24057433 |
| 12 | PLK2 | 2.20939515 |
| 13 | MINK1 | 2.18942442 |
| 14 | MAP2K4 | 1.95316154 |
| 15 | KSR2 | 1.88060499 |
| 16 | KSR1 | 1.81173037 |
| 17 | ARAF | 1.76633447 |
| 18 | PRPF4B | 1.76495040 |
| 19 | BMPR2 | 1.66047255 |
| 20 | PAK6 | 1.59207253 |
| 21 | PTK2B | 1.52743240 |
| 22 | GRK5 | 1.47768671 |
| 23 | CCNB1 | 1.40806777 |
| 24 | PNCK | 1.38646840 |
| 25 | MAP3K13 | 1.36922657 |
| 26 | CDK5 | 1.34140892 |
| 27 | MARK1 | 1.33871893 |
| 28 | AKT3 | 1.33357284 |
| 29 | CAMKK1 | 1.32755228 |
| 30 | PRKD3 | 1.30007618 |
| 31 | NME1 | 1.28655820 |
| 32 | NTRK2 | 1.26948055 |
| 33 | OXSR1 | 1.21285014 |
| 34 | PRKCG | 1.20398687 |
| 35 | FES | 1.18097350 |
| 36 | SIK3 | 1.15609561 |
| 37 | CAMK2A | 1.13684369 |
| 38 | RIPK1 | 1.12342161 |
| 39 | TNIK | 1.09775709 |
| 40 | NTRK1 | 1.09239966 |
| 41 | RAF1 | 1.07249764 |
| 42 | CAMK2B | 1.05885771 |
| 43 | CAMKK2 | 1.05315303 |
| 44 | SIK2 | 1.02949076 |
| 45 | MAPK13 | 0.99809670 |
| 46 | NEK6 | 0.94816121 |
| 47 | PHKG2 | 0.94386447 |
| 48 | PHKG1 | 0.94386447 |
| 49 | TAOK2 | 0.89545151 |
| 50 | SGK223 | 0.87842751 |
| 51 | SGK494 | 0.87842751 |
| 52 | LIMK1 | 0.87371774 |
| 53 | FGR | 0.87090286 |
| 54 | ALK | 0.86914355 |
| 55 | SGK2 | 0.86302213 |
| 56 | MAP3K2 | 0.84648768 |
| 57 | BRAF | 0.84568475 |
| 58 | CDK18 | 0.84307817 |
| 59 | STK38 | 0.83306805 |
| 60 | BRSK1 | 0.82339342 |
| 61 | CDK15 | 0.77103258 |
| 62 | CDK14 | 0.73896095 |
| 63 | CAMK1 | 0.73244795 |
| 64 | SGK1 | 0.67772317 |
| 65 | CDK11A | 0.66317656 |
| 66 | DAPK3 | 0.64587126 |
| 67 | TYRO3 | 0.62611665 |
| 68 | MAPK10 | 0.62211306 |
| 69 | MAP3K11 | 0.60667168 |
| 70 | MAP2K6 | 0.59359968 |
| 71 | STK11 | 0.58832735 |
| 72 | CSNK1G2 | 0.57718262 |
| 73 | DYRK1A | 0.56417777 |
| 74 | SGK3 | 0.55945016 |
| 75 | PDK1 | 0.55912305 |
| 76 | PRKCE | 0.55751953 |
| 77 | PKN1 | 0.54990379 |
| 78 | UHMK1 | 0.54072618 |
| 79 | PDPK1 | 0.53808180 |
| 80 | BCR | 0.53801260 |
| 81 | FER | 0.52682982 |
| 82 | PINK1 | 0.50339172 |
| 83 | GRK6 | 0.50184591 |
| 84 | MAP3K1 | 0.49952209 |
| 85 | CAMK2D | 0.49713000 |
| 86 | MAP2K1 | 0.48071921 |
| 87 | TESK1 | 0.47734088 |
| 88 | WNK1 | 0.46658758 |
| 89 | PRKCH | 0.45272316 |
| 90 | TNK2 | 0.44827929 |
| 91 | PDK4 | 0.44032628 |
| 92 | PDK3 | 0.44032628 |
| 93 | MAP3K6 | 0.43520120 |
| 94 | RET | 0.42995784 |
| 95 | FGFR2 | 0.42129951 |
| 96 | CAMK2G | 0.41404926 |
| 97 | TSSK6 | 0.40422564 |
| 98 | GRK7 | 0.39023891 |
| 99 | MAP3K7 | 0.37862740 |
| 100 | TAOK1 | 0.36374979 |
| 101 | RPS6KA3 | 0.35245524 |
| 102 | MAPK12 | 0.34882624 |
| 103 | MAPK7 | 0.34381610 |
| 104 | MOS | 0.33569882 |
| 105 | PAK3 | 0.33376390 |
| 106 | LATS2 | 0.33136405 |
| 107 | MARK2 | 0.32445344 |
| 108 | ADRBK1 | 0.32062033 |
| 109 | ROCK2 | 0.31884726 |
| 110 | PRKCZ | 0.30880557 |
| 111 | FYN | 0.30790861 |
| 112 | CAMK4 | 0.30052341 |
| 113 | PRKG2 | 0.30049154 |
| 114 | MUSK | 0.29721487 |
| 115 | PRKG1 | 0.29652939 |
| 116 | CDK3 | 0.29454304 |
| 117 | PRKACA | 0.29077806 |
| 118 | PRKCB | 0.28219108 |
| 119 | CAMK1G | 0.28141645 |
| 120 | PRKCA | 0.27892149 |
| 121 | ROCK1 | 0.27786500 |
| 122 | ERBB2 | 0.23751418 |
| 123 | CSNK1E | 0.23467982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.20406421 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.47047166 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 3.11386699 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.92019110 |
| 5 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.88001023 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.85463637 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.84638271 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63088464 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.62706961 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.54371967 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.45246148 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.33294126 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.25928727 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 1.98135986 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.92828292 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.92050601 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88826618 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.86769299 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.81556004 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77944208 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.77044195 |
| 22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.75910963 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.72840581 |
| 24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72460870 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.51879158 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.50808995 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.50483401 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44224383 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.42179700 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29241653 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.27859404 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27698028 |
| 33 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22620914 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.18301703 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18080448 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17616758 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.17493235 |
| 38 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15143619 |
| 39 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13930534 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09935141 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09143032 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.05959228 |
| 43 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05422532 |
| 44 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00723344 |
| 45 | Melanogenesis_Homo sapiens_hsa04916 | 0.99604584 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98327521 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96667750 |
| 48 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.95415972 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.94468167 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93363801 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.90435281 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89403488 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87528114 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86176229 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85805139 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80157441 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75401401 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74631169 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67400487 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64422201 |
| 61 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63233735 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61640801 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61638236 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60681878 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60009702 |
| 66 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59965439 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59331417 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55563908 |
| 69 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53821446 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53195225 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52468425 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48917497 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48827968 |
| 74 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47675616 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46726080 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44432254 |
| 77 | Mineral absorption_Homo sapiens_hsa04978 | 0.42241391 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41832653 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41706277 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.41336188 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37129409 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36818016 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36113950 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34972615 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34302669 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34267767 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32778806 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31770524 |
| 89 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30726684 |
| 90 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.30588356 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30392611 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.30179147 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30101981 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.29115991 |
| 95 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28901197 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27807707 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27143308 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26815188 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.24694199 |
| 100 | Tight junction_Homo sapiens_hsa04530 | 0.24303515 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23935376 |
| 102 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.23732849 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23408990 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.23341676 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.22137931 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.22057423 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.20202901 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20076095 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.19788839 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18930269 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18802980 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18180658 |
| 113 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.17450190 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.17152852 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15596717 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14451130 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14305886 |

